Glycoprotein G (gG) homologues have been found in most alphaherpesviruses although little is known about their structure or function. In this study, three species of equine herpesvirus-4 (EHV-4) gG were identified : a full-length 68 kDa virion-associated species (gGV L ), a 12 kDa virion-associated species (gGV S ) and a 60 kDa secreted species (gGS), detected in the medium of infected cells. gGS and gGV S appear to be proteolytic cleavage products of gGV L and correspond to the N-and C-terminal regions, respectively. It was shown that gGS and gGV L are similarly glycosylated possessing mostly N-linked complex-type carbohydrate side chains. Western blots of proteins separated under nonreducing conditions established that gGS is secreted as a 120 kDa glycoprotein while the virion-
Introduction
Glycoproteins of herpesviruses play important roles in the processes of virion attachment and penetration as well as in cell-cell fusion (Marsden, 1987 ; Spear, 1985) . Among the herpesviruses, the glycoproteins of herpes simplex virus-1 (HSV-1) are among the best characterized and 11 distinct glycoproteins have been identified. Of these, only four, gB, gD and the gH\gL complex, are essential for replication in vitro in cell culture, although it is presumed that the remainder serve important roles in vivo in viral pathogenesis. Glycoprotein G (gG) homologues have been identified in most alphaherpesviruses that have been examined (Colle et al., 1992 ; Crabb et al., 1992 ; Eberle et al., 1993 ; Ficorilli et al., 1995 ; Fukushi et al., 1997 ; Keil et al., 1996 ; Kongsuwan et al., 1993 ; McGeoch et al., 1987 ; Rea et al., 1985 ; Slomka et al., Fax j613 9416 2616. e-mail heidid!ariel.its.unimelb.edu.au associated species, gGV L and gGV S , are present in the virion as 140 and 20 kDa proteins, respectively. As gGS and gGV L do not appear to associate stably with other viral proteins, it is most likely that each species exists as a disulphide-linked homodimer. Pulse-chase experiments indicated that gGV L is rapidly assembled as a homodimer prior to both carbohydrate side-chain maturation in the Golgi and proteolytic cleavage. Proteolytic cleavage of full-length gG occurs during or immediately after passage through the Golgi. Secreted and virionassociated species of gG were identified in the closely related virus EHV-1 and were of similar molecular masses to the corresponding EHV-4 gG species.
1995 ; Spatz et al., 1994) . gG is unusual among herpesvirus glycoproteins in that a form of it is secreted into the medium of infected cells. Thus far, a secreted form of gG has been shown for six different gG homologues, including that of the evolutionarily distant avian alphaherpesvirus, infectious laryngotracheitis virus (ILTV) (Crabb et al., 1992 ; Keil et al., 1996 ; Kongsuwan et al., 1993 ; McGeoch et al., 1987 ; Rea et al., 1985) . The only exception is HSV-1 gG, which exists as an unusually truncated molecule and apparently lacks a secreted form. In contrast to other herpesvirus glycoproteins, which are under the transcriptional control of late promoters, gG homologues appear to be under the control of early promoters (Colle & O'Callaghan, 1995 ; Keil et al., 1996) . These data suggest that the in vivo role of gG is radically different to that of other herpesvirus glycoproteins.
Analysis of the amino acid sequences of all gG homologues, with the exception of HSV-1 gG, reveals extensive amino acid similarity at the N terminus. In this region, gG homologues possess eight cysteine residues (seven in HSV-2 gG) that are similarly spaced, including three that are invariably separated by either 11 and 10 or 13 amino acids, respectively. Their conserved nature suggests that they are structurally and functionally important. In addition, one site for N-linked glycosylation [at residue 137 in equine herpesvirus-4 (EHV-4) gG] is positionally conserved in all gG homologues except bovine herpesvirus-1 (BHV-1). BHV-1 gG is also unusual in that it is secreted in two forms : a 65 kDa glycoprotein and a glycoproteoglycan of between 90 and 240 kDa . While the function(s) of gG has not been determined, it is likely to be similar among all the alphaherpesviruses given their similar properties, notably secretion from infected cells and the likelihood of conserved structure of the secreted molecule.
HSV-2 gG is the best characterized of the gG homologues. The gene is located in the unique short region of the HSV-2 genome (US4) and is predicted to encode a 699 amino acid protein (McGeoch et al., 1987) . It has been shown that a 100 kDa non-glycosylated precursor of HSV-2 gG is modified in infected cells to a 104 kDa precursor by the addition of Nlinked high-mannose carbohydrate side chains (Su et al., 1987) . This species is cleaved into 72 and 31 kDa intermediates which are further processed to 108 and 34 kDa mature products by the modification of N-linked complex-type carbohydrates as well as the addition of O-linked carbohydrates (Balachandran & Hutt-Fletcher, 1985 ; Su et al., 1987) . The 34 kDa HSV-2 gG species is secreted into the extracellular fluid of infected cells and has been shown to comprise the N-terminal portion of the 104 kDa precursor molecule (Su et al., 1993) . Secretion of the 34 kDa protein is not dependent on the expression of other virion proteins (Su & Courtney, 1988 ; Su et al., 1993) .
EHV-4 and EHV-1 are related members of the subfamily Alphaherpesvirinae and cause respiratory disease in horses. EHV-1 is also a major cause of abortion and, occasionally, myeloencephalitis. Genes encoding gG homologues have been identified for both viruses (Colle et al., 1992 ; Crabb et al., 1992 ; Telford et al., 1992) and, in the case of EHV-4, a secreted form has been identified (Crabb et al., 1992) . Analysis of the primary amino acid sequence of EHV-4 and EHV-1 gG predicted that both molecules are type I integral membrane proteins and that the N-terminal 300 amino acids are relatively conserved (75 % identical). By contrast, the C-terminal 100 amino acids of EHV-4 and EHV-1 gG, adjacent to the predicted C-terminal transmembrane domains, are highly divergent and possess strong type-specific epitopes Drummer et al., 1995) .
In this study, we show that the glycosylation of EHV-4 gG species involves only N-linked complex-type carbohydrates. We also show that EHV-4 gG is secreted as a disulphide-linked homodimer and provide evidence for the existence of two different virion-associated species of gG that are also disulphide-linked homodimers. As with HSV-2 gG, proteolytic cleavage does not appear to require other viral proteins. EHV-1 gG was also shown to exist in both secreted and virionassociated forms.
Methods
Cell culture and viruses. Equine foetal kidney (EFK) cells, used between passage 5 and 7, or a cell line described by Crabb & Studdert (1990) were grown in minimum essential medium (MEM ; Gibco BRL) supplemented with 5 % foetal bovine serum, 0n08 M NaHCO $ , 0n015 M HEPES and 50 µg\ml ampicillin. EHV-4.405\76 was used between passage 3 and 10 and was grown in EFK monolayer cell cultures as described elsewhere (Studdert & Blackney, 1979) . EHV-4.405\76 was used at passage 20 for pulse-chase experiments in a cell line. Monolayer cell cultures were infected in 25 cm# cell culture flasks with 1-5 TCID &! per cell unless otherwise stated. Infected cells were maintained in serumfree MEM supplemented with 0n13 M NaHCO $ , 0n015 M HEPES and 50 µg\ml ampicillin (MM).
Virus was purified from infected cell culture medium that had been clarified at 800 g for 10 min. Extracellular virus was then pelleted at 100 000 g for 60 min and the resulting pellets were resuspended in TNE (0n05 M Tris, 0n5 M NaCl, 0n005 M EDTA, pH 7n5). Virus was purified on continuous 5-15 % Ficoll-400 gradients (LKB Pharmacia) at 20 000 g for 2 h. Virus was concentrated by centrifugation at 100 000 g and the resulting purified viral pellet was resuspended in TNE containing 1 mM PMSF and the concentration was adjusted to approximately 1 mg\ml. For experiments involving the use of secreted gG, 25 cm# flasks of EFK cells were infected for 1 h at 37 mC. The inoculum was removed, MM was added and the culture was incubated for 2-3 days. The cell culture medium was removed from infected cell cultures and clarified of cell-free virus and cellular debris by centrifugation at 100 000 g ; the resulting unconcentrated supernatant fluid (SNF) was used as a source of soluble secreted gG.
Antiserum. Antiserum specific for EHV-4 gG was raised in rabbits inoculated with purified Escherichia coli-expressed fusion protein. The variable region of EHV-4 gG, encompassing amino acids 287-374, was cloned into the expression vector pTrcHis (Invitrogen) and the expressed protein was purified on metal affinity columns (Talon ; Clontech) according to the manufacturer's instructions. Rabbits were inoculated three times with approximately 100 µg purified protein ; the first injection was with Freund's complete adjuvant followed by two injections 3 weeks apart with antigen emulsified in Freund's incomplete adjuvant. Serum was collected from the rabbits 1 week after their third inoculation for use in Western blotting and radioimmunoprecipitation assays (RIPA).
SDS-PAGE and Western blotting. SDS-PAGE and Western blotting to PVDF membranes (Millipore) were performed using standard techniques. Blots were probed with rabbit anti-EHV-4 gG serum diluted 1 : 500 in PBS containing 2n5 % skimmed milk and 0n05 % Tween-20 (PBSST) for 2 h. After three washes with PBSST, horseradish peroxidaselabelled swine anti-rabbit immunoglobulin (Dako) diluted in PBSST 1 : 1000-1 : 2000 was added and incubated for 1 h. Washed membranes were developed using an ECL protein detection kit (Amersham).
Radioimmunoprecipitation. Radiolabelled antigen was prepared in EFK monolayer cell cultures either infected with 5-20 TCID &! per cell EHV-4.405\76 or mock infected. After 1 h adsorption, the inoculum was removed and replaced with MM. Six to eight hours after infection, MM was removed and replaced with serum-free methionine\cysteine-deficient DMEM (ICN) containing 0n13 M NaHCO $ , 0n015 M HEPES, 50 µg\ml ampicillin and 100 µCi [$&S]methionine\cysteine Tran$&S-Label (ICN) for 3 days. Cells were scraped into the cell culture medium and viral and cellular proteins were pelleted at 100 000 g. The cell pellet was disrupted in RIPA lysis buffer (0n05 M Tris-HCl pH 7n5, 1 % Triton X-100, 0n6 M KCl, 1 mM PMSF) and sonicated briefly (cell lysate) and the SNF was used as a source of secreted radiolabelled gG. Radiolabelled cell protein and SNF were pre-cleared by incubation with pre-immune rabbit serum (25 µl\ml antigen) for 1 h on ice and then used to resuspend a 25 µl pellet of protein G beads three times. RIPA were performed by incubating protein G beads and antibody diluted 1 : 20 in RIPA buffer (0n05 M Tris-HCl, pH 8n0, 1 mM EDTA, 0n15 M NaCl, 0n25 % w\v BSA, 1 % Triton X-100) for 30 min at 4 mC. Beads were washed three times with RIPA buffer before the addition of 250 µl pre-cleared antigen and then incubated for a further 30 min at 4 mC. The beads were washed twice with RIPA buffer and twice with PBS and resuspended in sample buffer with (reducing buffer) or without (non-reducing buffer) 1 % dithiothreitol. Samples were boiled for 3 min before electrophoresis on SDS-PAGE gels and Biomax film (Kodak) was used for autoradiography.
Pulse-chase experiments. Pulse-chase experiments were performed as described by Flowers et al. (1995) . Briefly, cell monolayers in 25 cm# flasks (Nunc) were infected for 6 h with 40 TCID &! per cell of EHV-4.405\76. The monolayers were then washed three times with PBS and starved of methionine and cysteine for 30 min by incubation in methionine\cysteine-deficient DMEM. The monolayers were then pulsed with 200 µCi [$&S]methionine\cysteine Tran$&S-Label for 15 min. Excess label was washed away with MM containing ten times the normal concentration of methionine and incubated in this medium for various lengths of time. SNF and cells were prepared as described for the RIPA experiments above.
Carbohydrate analysis of gG. Prior to the addition of deglycosylating enzymes, purified virus or SNF from infected cell cultures in buffer consisting of 100 mM sodium acetate (pH 7n0), 0n1 % SDS, 1 mM PMSF and 2 mM EDTA were boiled for 2 min before the addition of noctyl glucoside to 1 %. Deglycosylation was performed with 10 mU neuraminidase (Clostridium perfringens ; Sigma) for 1 h at 37 mC followed by 1 mU O-glycosidase (Boehringer Mannheim) for 4 h to remove Olinked carbohydrates and\or 2 U N-glycosidase F (Boehringer Mannheim) for 4 h to remove N-linked carbohydrates.
Endoglycosidase H (Boehringer Mannheim) digestions were performed in 100 mM sodium acetate (pH 5n5), 0n1 M 2-mercaptoethanol, 0n01 % SDS, 0n1 % n-octyl glucoside and 1 mM PMSF for 6 h at 37 mC using 1 mU of enzyme.
Studies using inhibitors of carbohydrate attachment were performed by growing EHV-4.405\76 in EFK monolayer cell cultures in the presence of 1-deoxymannojirimycin (1 mM ; Sigma) or tunicamycin (2 µg\ml ; Boehringer Mannheim) and [$&S]methionine\cysteine Tran$&S-Label.
Images. Images of Western blots and autoradiographs were scanned on a Nikon Scantouch desktop scanner using Adobe Photoshop 3.0 and annotated using Adobe Illustrator 6.0.
Results

EHV-4 gG is present in both secreted and virionassociated forms
A secreted form of EHV-4 gG was identified previously in the cell culture medium of infected cells as a 63 kDa glycoprotein using affinity-purified antiserum raised in horses experimentally infected with EHV-4 (Crabb et al., 1992) . In this study, a rabbit antiserum was raised to the immunogenic EHV-4 gG variable region encompassing amino acids 287-374. Using this antiserum in Western blotting experiments, two major gG-related proteins, with an apparent molecular mass of 68 kDa and 12 kDa, respectively, were detected in purified virions (Fig. 1 a) . The secreted form of gG in the SNF of infected cells was also observed at 60 kDa, which we believe is the same as the 63 kDa protein previously described (Crabb et al., 1992) (Fig. 1 a) . An apparent molecular mass of 60 kDa, rather than 63 kDa, was observed consistently over many experiments and so we have amended the molecular mass of this species to 60 kDa. No reactivity to any of these proteins was observed with pre-bleed serum obtained from the same rabbit (data not shown) confirming their identity as gG-related viral proteins. We propose, and provide evidence (see below), that the 68 kDa virion-associated species represents the fulllength, integral membrane form of gG and that the 12 kDa virion-associated and 60 kDa secreted species represent proteolytic cleavage products of full-length gG corresponding to the C-and N-terminal regions, respectively.
To investigate the oligomeric structure of EHV-4 gG, purified virions and SNF from infected cell cultures were separated by SDS-PAGE under non-reducing conditions, transferred to PVDF membranes and probed with the rabbit anti-gG serum. Two major virion-associated species of gG, at 140 and 20 kDa, and one secreted form of gG at 120 kDa were detected (Fig. 1 a) . This suggested that the 140, 120 and 20 kDa species were disulphide-linked homodimers of the 68, 60 and 12 kDa gG-related species, respectively, observed under reducing conditions. These forms were termed gGV L (68 kDa\140 kDa), gGS (60 kDa\120 kDa) and gGV S (12 kDa\20 kDa).
Radiolabelled viral proteins were immunoprecipitated and separated by SDS-PAGE under reducing conditions. Diffuse proteins of similar molecular mass ; approximately 60-62 kDa, were detected in both the infected cell lysate and the SNF (Fig.  1 b) . A 68 kDa species, such as that observed in virions, is absent in infected cells because a partially glycosylated intermediate form of gGV L at 60-62 kDa is the dominant gGrelated species detected in these cells (see Fig. 3 ). Importantly, whether in the infected cell or the supernatant, only a single species was detected. When the same samples were run under non-reducing conditions, single species of approximately 120 kDa were observed in both the cell lysate and SNF (data not shown). Together, these data indicated that oligomeric gG is probably not disulphide-linked to other viral proteins. In this experiment, the 12 kDa virion-associated species was not detected, although it was observed as a faint but distinct band in other experiments (see Fig. 4 ).
EHV-4 gG is modified by the addition of complex-type carbohydrates
HSV-2 gG contains four sites for N-linked glycosylation and is extensively O-glycosylated between amino acids 347 and 537, a region containing large numbers of serine and threonine residues (Serafini-Cessi et al., 1985) . The amino acid sequence of EHV-4 gG predicts five sites for N-linked glycosylation but does not have serine-or threonine-rich regions, suggesting a lack of O-linked glycosylation. Deglycosylating enzymes were used to determine the extent of N-and O-linked glycosylation. Both gGV L and gGS were highly 3) and SNF prepared from cell culture medium from infected cells (lanes 2 and 4) with rabbit anti-EHV-4 gG serum (lanes 3 and 4) or pre-immune rabbit serum (lanes 1 and 2) and analysed on 12n5 % reducing SDS-PAGE gels. The identity of gGV L , gGV S and gGS and their approximate molecular masses are shown. Arrows on the right indicate the location of the major gG related proteins and their approximate molecular mass ; molecular mass standards (kDa) are shown on the left. sensitive to N-glycosidase F treatment showing increased mobilities to 46 and 42 kDa, respectively (Fig. 2 a, b) . Furthermore, endoglycosidase H (EndoH) treatment of purified virions or SNF from infected cells did not increase the mobility of gGV L and gGS significantly, suggesting that the N-linked carbohydrate on these molecules is mostly complex-type (Fig.  2 a, b) . The mobility of the 12 kDa species, gGV S , was not altered by N-glycosidase F treatment indicating that this polypeptide does not contain N-linked carbohydrates. A doublet was commonly observed in gGS and gGV L treated with N-glycosidase F most likely due to incomplete deglycosylation. However, we cannot rule out the possibility that gGV L is cleaved at two sequences in close proximity which would give rise to two different molecular mass forms of gGV L , gGV S and gGS.
In order to determine the extent of O-linked glycosylation, purified virions and SNF were treated with O-glycosidase. Samples were pre-incubated with neuraminidase to remove terminal sialic acid residues, necessary for the activity of Oglycosidase. Neuraminidase treatment alone did not substantially alter the mobility of gGV L although a slight increase in the mobility of gGS was observed following treatment (Fig . Fig. 3 . Growth of EHV-4 in the presence of glycosylation inhibitors. gG was immunoprecipitated with rabbit anti-EHV-4 serum from [
35 S]methionine/cysteinelabelled infected-cell proteins (lanes 1-4) and SNF prepared from infected cell culture medium (lanes 5-8) harvested from mock-infected untreated cells (lanes 1 and 5) and infected cells that were either untreated (lanes 2 and 6) or maintained in the presence of 1-deoxymannojirimycin (lanes 3 and 7) or tunicamycin (lanes 4 and 8). Samples were separated on 5-20 % SDS-PAGE gradient gels under reducing conditions. Approximate molecular masses of gGrelated species are given and the probable identities of processing intermediates of the virion-associated proteins (gGV L and gGV S ) and secreted protein (gGS) are indicated. Molecular mass markers are shown on the left (kDa).
a, b)
. No significant reduction in molecular mass was observed for any neuraminidase-treated gG species using O-glycosidase indicating that O-linked carbohydrate is probably not attached to any gG-related species. This was further confirmed by treatment with a combination of N-glycosidase F, neuraminidase and O-glycosidase which produced the same molecular mass for each species as was observed with Nglycosidase F alone (Fig. 2 a, b) . The high molecular mass species seen in Fig. 2 (a) was commonly observed in reducing gels (see also Fig. 4 ) and most likely represents dimeric gG. It is possible that despite reduction of the disulphide linkages, strong hydrophobic interactions are involved in maintaining these associations. Control experiments to confirm the activity of the neuraminidase and O-glycosidase were performed in parallel with the above experiments. These included the enzymatic digestion of EHV-1 virions with these enzymes followed by immunoblotting and detection of EHV-1 gp2, a highly O-glycosylated protein, with the specific MAbs 8B6 and 1G12 (Allen & Yeargan, 1987 ; Wellington et al., 1996) (data not shown).
Inhibitors of glycosylation were used to confirm the nature of N-linked carbohydrate on EHV-4 gG and intermediates in the processing events. The activity of α-mannosidase I in the cis-Golgi is inhibited by 1-deoxymannojirimycin, thereby preventing the conversion of N-linked carbohydrate from high-mannose to complex-type (Legler & Juelich, 1984) . In the SNF of EHV-4-infected cells grown in the presence of 1-deoxymannojirimycin, a gG-related species of 56 kDa, 4 kDa smaller than mature gGS, was detected (Fig. 3) . A 56 kDa glycoprotein was also observed in 1-deoxymannojirimycintreated cells, but not in untreated cells, suggesting that the cleaved N-terminal portion of gG, in addition to being found in the supernatant, may be associated with the infected cell. The major gG-related species present in EHV-4-infected cells grown in the presence of 1-deoxymannojirimycin was a 60 kDa glycoprotein and this was the same molecular mass as the major species present in untreated infected cells (Fig. 3) . This suggested that high-mannose precursors of gGV L are the dominant gG-related species in untreated infected cells. Presumably because of this, we consistently had difficulty in detecting significant quantities of the mature 68 kDa form of gGV L in infected cells prepared in this way but we did detect this species in pulse-chase experiments (see below). The presence of secreted gG in the SNF of 1-deoxymannojirimycintreated cells indicates that cleavage of gG is not dependent on the presence of N-linked complex-type carbohydrates. It is interesting to note that in untreated infected cells, the highmannose intermediate form of gGS was not detected despite the abundance of the high-mannose intermediate of the presumed precursor of gGS, gGV L . This suggests that the proteolytic cleavage of gGV L occurs along with, or after, carbohydrate maturation through the Golgi apparatus. This is addressed further in the pulse-chase experiments described below.
Tunicamycin treatment, which inhibits the en bloc addition of the N-linked oligosaccharide precursor to nascent polypeptides in the endoplasmic reticulum, resulted in the accumulation of a small amount of a gG-related species of 49 kDa in infected cells (Fig. 3) , similar to the molecular mass of N-glycosidase F-treated gGV L (Fig. 2) and probably corre- sponding to the unglycosylated form of gGV L . There was no detectable accumulation of gGS in the SNF in the presence of tunicamycin, suggesting that glycosylation is essential for correct processing, intracellular trafficking and secretion of gG.
Kinetics of post-translational processing
To examine the kinetics of the post-translational processing of gG, pulse-chase experiments were performed and the immunoprecipitated, metabolically labelled products were examined under reducing and non-reducing conditions. At the commencement of the chase period, the major form of gG present under reducing conditions is the 60 kDa high-mannose gGV L precursor (Fig. 4 a, lane 2) . From the gel run under nonreducing conditions, it was apparent that this species is rapidly assembled into a disulphide-linked homodimer of 120 kDa (Fig. 4 b, lane 2) . The fully glycosylated form of gGV L , 68 kDa (reducing conditions) and 140 kDa (non-reducing), is first apparent at 15 min chase (Fig. 4 a, b, lane 3) and the proportion of this species with respect to the high-mannose intermediate steadily increases over the chase period reaching a maximum at 90-105 min chase (Fig. 4 a, b, lanes 8 and 9) . EndoH digestion of the immunoprecipitated cell lysates confirmed that at 0 min chase the majority of this species was sensitive to EndoH digestion but that gG was steadily converted to increasingly resistant forms beginning at 15 min chase (data not shown). Also apparent for about the first 60 min of the chase period is a faint gG-related species at 56 kDa observed under reducing conditions. A corresponding 100 kDa species was observed under non-reducing conditions which presumably represents a dimeric form of the 56 kDa species. The 56 kDa species corresponds in size to high-mannose forms of gGS observed in cells and in cell culture supernatant following treatment with 1-deoxymannojirimycin and so perhaps represents this species (Fig. 3) . It is also sensitive to EndoH digestion (data not shown). Alternatively, this species may represent, particularly very early on in the chase, less mature forms of full-length gG.
The appearance of the 12 kDa gGV S species in infected cell lysates appeared to correspond to carbohydrate sidechain maturation of gGV L reaching maximal abundance at 90-105 min chase (Fig. 4 a, lanes 8 and 9) . This suggests that proteolytic cleavage of full-length gG occurs along with, or shortly after, the conversion in the Golgi apparatus of carbohydrate side chains from high-mannose to complex-type. The secreted species, gGS, was first detected in the SNF at 30-45 min chase and was present at all times as a 120 kDa disulphide-linked homodimer of the fully glycosylated 60 kDa species (Fig. 4 c, d ). These samples were subjected to EndoH digestion and, as expected, the gGS species was EndoHresistant throughout the chase (data not shown). gGS reached maximal abundance by 135-150 min chase, which is consistent with the requirement for the secreted species to traffic to the surface, presumably in secretory vesicles, from the site of proteolytic cleavage. This is also consistent with the presence of a 120 kDa dimer of gG observed throughout the chase which initially represents a high-mannose form, gGV L , but later represents the fully mature cleaved form, gGS, which has not yet been exported from the cell (Fig. 4 b, lanes 2-12) .
Discussion
Previously, we identified and characterized EHV-4 gG as an abundant secreted protein detectable in small volumes of unconcentrated cell culture medium from infected cultures (Crabb et al., 1992) . Studies of this molecule, and its EHV-1 homologue, have focused on small, highly variable and strongly immunogenic regions which have been used as antigens for detecting type-specific antibodies to these viruses Drummer et al., 1995) . The nucleotide and amino acid sequence of EHV-4 gG has been shown to differ from the published sequence (Nagesha et al., 1993) . The size of the open reading frame has been amended from 405 to 435 amino acids and several amino acid differences were observed at the C terminus of the molecule, including the region that forms the basis of the type-specific ELISA (A. J. Davison, personal communication ; GenBank accession number AF030027) ; these corrections have been confirmed in our laboratory (C. A. Hartley, unpublished observations). The amino acids that encompass the EHV-4 gG type-specific ELISA are amended from 287-382 to 287-374 and the length of the transmembrane region and cytoplasmic tail is amended from 21 to 54 amino acids. In this paper, identification and characterization of EHV-4 gG was performed using antiserum prepared to the variable region of EHV-4 gG encompassing amino acids 287-374. The reactivity of this antiserum with the two proteolytic forms of gG indicates that the epitopes recognized by this antiserum reside on either side of the cleavage site. The 68 kDa fully reduced and disassociated form identified in the virion most likely constitutes full-length gG which becomes embedded in the viral envelope via its Cterminal transmembrane domain (Fig. 5) . The 12 kDa form of gG is also virion-associated and so must also encompass the Cterminal transmembrane domain. The 60 kDa secreted form of gG presumably constitutes the N-terminal external domain of gG released following proteolytic cleavage of the full-length molecule in the Golgi or a post-Golgi vesicle (Fig. 5) . Unpublished data from our laboratory using antiserum raised to the variable region of EHV-1 gG suggest gG is also secreted as a 55 kDa species and that two species can be found within the virion of molecular masses 66 kDa and 10-12 kDa (H. E. Drummer, unpublished data). Similarly, the cleavage site for EHV-1 gG must be located within the variable region given that all three gG-related species can be detected with the monospecific antiserum raised to this region of the molecule. Examination of this region of EHV-4 and EHV-1 gG does not reveal any similarity to sequences recognized by enzymes commonly involved in cleavage of glycoproteins, including the mammalian subtilisins (for review see Barr, 1993) and may suggest that gG uses a novel mechanism to release the secreted form from the full-length molecule.
Each of the three gG-related species exists as a disulphidelinked homodimer. To our knowledge, this is the first time any aspect relating to the oligomerization of a gG homologue has been examined. Three cysteine residues are potentially present in gGV S , two of which occur in the predicted transmembrane region and are unlikely to be involved in the formation of intermolecular disulphide bonds (Fig. 5) . It is therefore probable that Cys$(( is involved in the intermolecular disulphide bonding to form the 20 kDa homodimer of gGV S . Other intermolecular disulphide bridges must clearly be formed in the full-length gG molecule given that the secreted form (gGS) also forms intermolecular disulphide bonds. Three cysteine residues, separated by 11 and 10 or 13 amino acids residues, are positionally conserved in all gG homologues sequenced to date. It is likely that these cysteine residues are involved in forming disulphide bridges and are important to the structure and function of the molecule.
Two secreted species of BHV-1 gG have been identified, a 65 kDa glycosylated protein and a 90-240 kDa glycoproteoglycan which comprises the 65 kDa species modified by the addition of chondroitin sulphate . Experiments were performed in order to determine whether EHV-4 gG is similarly modified. Large molecular mass species similar to that identified for BHV-1 gG were not identified for EHV-4. Furthermore, the mobility and the abundance of gGV L , gGV S or gGS were not altered following chondroitinase ABC treatment (data not shown). The absence of chondroitin sulphate modification of EHV-4 gG was confirmed by the Fig. 5 . Schematic representation of EHV-4 gG. Hydrophobic regions ( ) predicted to be an N-terminal signal peptide and a Cterminal transmembrane spanning region, regions encompassing conserved N-terminal portion and cytoplasmic tail (), variable region ( ) to which antiserum was raised and the region between the variable domain and C-terminal transmembrane region (9) are indicated. The positions of 13 cysteine residues (C) are indicated, including three cysteine residues spatially conserved in all secreted alphaherpesvirus gG homologues shown in bold. The region constituting the three gG-related proteins described in this paper is shown below and the scale in amino acids residues is shown above.
growth of EHV-4 in the presence or absence of methylumbelliferyl-β--xyloside (Schwartz, 1979) . Methylumbelliferyl-β--xyloside is an inhibitor of the substitution of core serine residues with polymers of chondroitin sulphate but does not prevent synthesis of free chondroitin sulphate chains. Growth of EHV-4 in the presence of 3 or 10 mM methylumbelliferyl-β--xyloside did not result in altered sizes or relative abundance of gG-related proteins (data not shown) indicating that there is no covalent attachment of chondroitin sulphate.
Analysis of the extent of glycosylation showed that both the 60 kDa secreted (gGS) and the 68 kDa (gGV L ) virionassociated forms of EHV-4 gG are extensively N-glycosylated with complex-type carbohydrate side-chains, but no evidence for O-linked glycosylation was found. The absence of O-linked carbohydrate contrasts with BHV-1 gG and HSV-2 gG which are both extensively O-glycosylated (Balachandran & HuttFletcher, 1985 ; Keil et al., 1996 ; Su et al., 1987) . O-Linked carbohydrates have been shown to play important roles in stabilizing the secondary structures of proteins, particularly in providing resistance to proteolytic degradation, and may also have a role as ligands (Kobata, 1992 ; Takeuchi & Kobata, 1991) . EHV-4 gG is apparently more heavily N-glycosylated than other gG homologues. If O-linked glycans are required merely for reasons of stability, then it is possible that N-linked glycans compensate for the absence of O-glycans in this molecule. Alternatively, it is possible that the gG homologues may not have common roles if the O-linked glycans are pivotal for their function.
Identification of gG as a component of the envelope of both EHV-4 and EHV-1 is significant in that, with the exception of HSV-1 gG, this glycoprotein has not been characterized for any other alphaherpesvirus. Specifically, HSV-2, pseudorabies virus, herpesvirus simiae, BHV-1, BHV-5 and ILTV gG homologues have not been shown to be integral components of the viral envelope although gG-related species have been identified in infected radiolabelled cells (Balachandran & HuttFletcher, 1985 ; Bennett et al., 1986 ; Keil et al., 1996 ; Kongsuwan et al., 1993 ; Slomka et al., 1995) .
Whether gG homologues from other alphaherpesviruses possess these virion-associated forms remains to be determined.
gG is non-essential for growth of herpesviruses in cell culture but its functional role(s) in vivo has yet to be determined. While at first glance the gG homologues appear relatively variable, both in amino acid identity and overall length, they show considerable conservation at the N terminus, particularly in terms of the position of the cysteine residues. With the notable exception of HSV-1 gG, the relatively conserved Nterminal region is secreted suggesting a common function for this portion of the gG homologues. Furthermore, gG transcription follows early kinetics, which is unusual for herpesvirus glycoproteins and suggests an important role in viral pathogenesis (Colle & O'Callaghan, 1995 ; Keil et al., 1996) . In addition to the secreted form, we have identified two virion-associated species of EHV-4 gG. The observation that two alternative forms of EHV-4 gG are carried into virions raises the intriguing possibility that gG may have multiple functions and that virion-associated and secreted forms are distinct entities in the pathogenesis of EHV-4 and EHV-1 infections.
